Skip to content
Aussie8 – Lifestyle
Author:
Arnatar Therapeutics, Inc.
Arnatar Therapeutics Receives China NMPA Clearance to Initiate First-in-Human Study of ART5, a First-in-Class Up-Regulating ASO Designed to Restore Polycystin-1 for the Treatment of ADPKD
July 7, 2026